Prediction of bone loss in patients with primary hyperparathyroidism using quantitative bone SPECT

Journal of Nuclear Medicine

Volumn 39, Issue 9, 1998, Pages 1614-1617

  Israel, Ora ^a   Gips, Sara ^b   Lubushitzky, Rafael ^b   Bettman, Lise ^b   Iosilevsky, Galina ^b   Hardoff, Ruth ^b   Baron, Elzbieta ^b   Daoud, Deeb ^b   Kolodny, Gerald M ^b   Front, Dov ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Bone loss; Hyperparathyroidism; Quantitative SPECT

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MALE; PREDICTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BONE DENSITY; BONE RESORPTION; FEMALE; FEMUR NECK; HUMANS; HYPERPARATHYROIDISM; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031658975     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wells SA. Surgical therapy of patients with primary hyperparathyroidism: long-term benefits. J Bone Miner Res 1991;6(suppl 2):S143-S149.
2. Mole PA, Walkinshaw MH, Gunn A, et al. Bone mineral content in patients with primary hyperparathyroidism: a comparison of conservative management with surgical treatment. Br J Surg 1992;79:263-265.
3. Clark OH, Wilkes W, Siperstein AE, et al. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy and deficiencies in our knowledge. J Bone Miner Res 1991;6(suppl 2):S135-S142.
4. Silverberg SJ, Gartenberg F, Jacobs TP, et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995; 80:729-734.
5. Peacock M. Interpretation of bone mass determinations as they relate to fracture: implications for asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991;6(suppl 2):S77-S82.
6. Fogelman I. An evaluation of the contribution of bone mass measurements to clinical practice. Semin Nucl Med 1989;21:62-68.
7. Iosilevsky G, Israel O, Frenkel A, et al. A practical SPECT technique for quantitation of drug delivery to human tumors and organ absorbed radiation dose. Semin Nucl Med 1989;19:33-46.
8. Front D, Israel O, Jerushalmi J, et al. Quantitative bone scintigraphy using SPECT. J Nucl Med 1989;30:240-245.
9. Israel O, Front D, Hardoff R, et al. In vivo SPECT quantitation of bone metabolism in hyperparathyroidism and thyrotoxicosis. J Nucl Med 1991;32:1157-1161.
10. Israel O, Gips S, Hardoff R, et al. Bone loss in patients with chronic renal disease: prediction with quantitative bone scintigraphy with SPECT. Radiology 1995;196:643-646.
11. Parfitt AM. Surface specific bone remodeling in health and disease. In: Kleerekoper M, Krane S, eds. Clinical disorders of bone and mineral metabolism. New York: Mary Ann Liebert; 1987: 7-14.
12. Silverberg SJ, Shane E, De La Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989;4:283-291.
13. Heath H. Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology. J Bone Miner Res 1991:6(suppl 2):S63-S70.
14. Martin P, Bergmann P, Gillet C, et al. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med 1990;150:1495-1497.
15. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity and potential impact in a community. N Engl J Med 1980;302:189-193.
16. Potts JT. Management of asymptomatic hyperparathyroidism. J Clin Endocrinol Metab 1990;70:1489-1493.